- Home
- SRV vs MYO Comparison
SRV vs MYO Comparison
Compare SRV & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRV
- MYO
- Stock Information
- Founded
- SRV 2007
- MYO 2004
- Country
- SRV United States
- MYO United States
- Employees
- SRV N/A
- MYO N/A
- Industry
- SRV Finance Companies
- MYO Industrial Specialties
- Sector
- SRV Finance
- MYO Health Care
- Exchange
- SRV Nasdaq
- MYO Nasdaq
- Market Cap
- SRV 185.8M
- MYO 153.0M
- IPO Year
- SRV N/A
- MYO 2017
- Fundamental
- Price
- SRV $43.77
- MYO $1.00
- Analyst Decision
- SRV
- MYO Strong Buy
- Analyst Count
- SRV 0
- MYO 3
- Target Price
- SRV N/A
- MYO $8.17
- AVG Volume (30 Days)
- SRV 33.9K
- MYO 1.3M
- Earning Date
- SRV 01-01-0001
- MYO 08-11-2025
- Dividend Yield
- SRV 13.38%
- MYO N/A
- EPS Growth
- SRV N/A
- MYO N/A
- EPS
- SRV N/A
- MYO N/A
- Revenue
- SRV N/A
- MYO $40,760,091.00
- Revenue This Year
- SRV N/A
- MYO $52.68
- Revenue Next Year
- SRV N/A
- MYO $28.33
- P/E Ratio
- SRV N/A
- MYO N/A
- Revenue Growth
- SRV N/A
- MYO 93.08
- 52 Week Low
- SRV $30.73
- MYO $0.92
- 52 Week High
- SRV $44.30
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- SRV 59.59
- MYO 16.39
- Support Level
- SRV $42.26
- MYO $0.95
- Resistance Level
- SRV $44.45
- MYO $1.16
- Average True Range (ATR)
- SRV 0.66
- MYO 0.12
- MACD
- SRV 0.09
- MYO -0.09
- Stochastic Oscillator
- SRV 62.35
- MYO 6.47
About SRV NXG Cushing Midstream Energy Fund of Beneficial Interest
NXG Cushing Midstream Energy Fund is a non-diversified, closed-end management investment company with an investment objective of seeking a high after-tax total return from a combination of capital appreciation and current income. The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in midstream energy investments.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).